| My Account | Sitemap | Subscribe | Contact Us | ||
|
Are vitamins and supplements really necessary for people with diabetes? John White discusses the nature and eff ects of the most common ones people take in addition to their medications.
The verdict is in, says John White: Despite some intriguing initial results, subsequent studies have pretty much laid to rest cinnamon’s reputation as a pseudo-insulin.
There are so many non-sugar sweeteners out there – where to begin? Well, begin here as the famous medical duo of Drs. Michael and Mary Dan Eades explore the pros and cons of various artifi cial sweeteners.
Out of shape? Want to get better? Well, working your abdominals to get them into fi ghting trim is the classic way to start an exercise program. Ann Swank tells you how.
Diabetes Health Digital Advantage™, the free, online version of Diabetes Health magazine, virtually identical to the bi-monthly Diabetes Health print magazine, has many additional useful features.
While the pages turn in a similar fashion to a magazine's, direct hot links lead to research articles, products and advertiser sites.
Access to the amazing Diabetes Health Digital Advantage™ is through any web browser, so you can read the current issue of Diabetes Health magazine online wherever you are!
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.

Latest Low Blood Sugar (Hypoglycemia) Articles
In an Italian study to compare once-daily injections of insulin glargine (Lantus) with once-daily injections of insulin detemir (Levemir), 24 patients with type 1 diabetes were treated for two weeks with either one or the other in a randomized double-blind study.
At the study's outset, the patients were injected with 0.35 units of insulin per kilogram, which comes to about 28.6 units for a 180-pound man. (See Dr. Bernstein's article about "long-acting" insulins for his opinion about giving experimental subjects high doses of long-acting insulin, "In My Opinion: There is No 24-Hour Basal Insulin")
Plasma glucose was clamped at 100 mg/dl for the 24 hours after the insulin injections. This means that for the 24 hours after the insulin injection, to prevent hypoglycemia, the patients were infused with just enough glucose to keep their blood sugar from dropping below 100 mg/dl.
With glargine, blood sugar remained at about 103 mg/dl for up to 24 hours. With detemir, things were fine for about sixteen hours, but then blood sugar began to increase progressively.
The glucose infusion rate was similar between the two insulins for twelve hours, after which it dropped more rapidly with detemir. Only about a third of the detemir subjects completed the study with blood sugar levels below 180 mg/dl.
The researchers, led by Francesca Porcellati, MD, concluded that glargine and detemir are similar for the first twelve hours, but that detemir begins to poop out during the second twelve hours.
Source: Diabetes Care, September 2007
837 comments - 26 Apr 2007
146 comments - 29 Nov 2007
76 comments - 13 Mar 2007
73 comments - 10 Apr 2008
63 comments - 23 Feb 2008
53 comments - 18 Jan 2008
Comments...
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register..
Register your Diabetes Health Username here.
Can a cost comparison be made available between Glargine and Detemir to understand the cost of treatment with both the drugs
- Chandrakant Kathote
As recently pointed out in a review of clamp studies by Heise et al (Diabetes, Obesity & Metabolism, 2007), the Porcellati group is the only group to have been able to demonstrate a protracted duration of action for insulin detemir. Three other studies have demonstrated 24-hour duration of action of insulin detemir in patients with type 1 and type 2 diabetes. These studies also show significantly less within-subject variability, thereby reducing the risk of hypoglycaemia and allowing clinicians and patients to more effectively titrate insulin dose.
As a CDE, I've seen both of these insulins last 24 hrs and "poop out" within 24 hrs. I believe there are individual differences in how the body uses meds. Another reason why someone with diabetes has to be treated individually.
As a user of both of these insulins, Lantus peaks 6-10 hours after injection and has never lasted 24 hours. Detemir lasts almost 24 hours with a much smoother action and less of a peak. Lantus always has required 2 doses a day for me to work. (12-14 units basal per24 hours)
I have used both Lantus and Detemir as my Basal Insulin.
With Detemir I find that I have to take almost 35% more insulin compared to Lantus for blood glucose consistency.
In addition, I found that I had experienced more episodes of Hypoglycemia with Lantus than Detemir and both required a 2Xday injections as well.
Itching continues to occur at the site injection with Detemir while none had occurred using Lantus.
I have also used both Lantus and Detemir as my Basal Insulin. Detemir did not last nearly as long. I had to take it every 8 hours (3X/day), and it had a more pronounced peak. I returned to Lantus, taking it twice a day, at 11 units each shot. Lantus works best for me.
Levemir works very well when metformin is introduced into therapy. FBS are now
lantus is more effective than detemir.. It is backed up by several studies wherein it is used once daily.
No one need look any further than the product package inserts. Levemir is dose dependent, lasting as little as 5.7 hours at a dose of 0.1 units per kilogram vs. 23.2 hours at a dose of 1.6 units per kilogram. Do the math. For Levemir to last a full 24 hours, a 220 pound man would have to take in excess of 160 units per day. And by looking at the PK/PD profile of insulin detemir, the higher the dose, the higher the peak action, even greater than the accepted peak of NPH. The "Medical Letter" even concludes that Levemir is a BID medication, and more recent studies have shown that more Levemir is required to achieve the same glucose lowering effect as either NPH or Glargine. I'm still confused as to why some individuals see an advantage to taking an intermediate acting insulin like Detemir to a long acting insulin like Glargine.
Is .35 units per kilo a standard dose? I thought patients took much more than that.
Every study done by Sanofi-Aventis is done at a single dose level which is a typical dose range of 0.4U/kg. Their so-called peakless profile has never been reproduced in any other study than the Lepore study. If they were to actually do a study with 0.1 or 0.2U/kg they would also find that they do not last 24 hours but much less. Their PI indicates that they were not even successful at controlling the A1c as good as NPH. The variability of intrasubject sugar control is double that of Levemir leading to weight gain, greater hypoglycemia. It is simple pharmacodynamics that all medicines have a rise to a peak and a fall which makes them dose dependent. Somehow people think that Lantus goes directly to a peak level and stays there until the magical time of 24 hours and then it all completely disappears. This is simply inaccurate and misleading. The conclusion that one would require 160 units per day is completely false. The advantage to an additional 24 hour basal such as Levemir vs Lantus is more consistent sugar control, less hypoglycemia, and low to no weight gain.
I am confused. It says in the lantus p.i. that, "The median time between injection and the end of pharmacological effect was 14.5 hours (range: 9.5 to 19.3 hours) for NPH human insulin, and 24 hours (range: 10.8 to >24.0 hours) (24 hours was the end of the observation period) for insulin glargine." Does this mean that Lantus can only last 10 hours at a low dose like NPH and have to be taken twice a day?
Have Your Say...